Introduction
In response to DNA damaging agents such as ionizing radiation (IR), cell cycle checkpoints are induced to delay cell cycle progression and support repair of the damage. These checkpoints are induced by the cells capabilities to recognize the DNA lesions and transmit signals to downstream proteins, ultimately affecting the cell cycle regulatory proteins (reviewed in Kastan and Bartek, 2004) .
When repair of the DNA lesions is completed, the signal recognizing the DNA lesions will cease, and cell cycle progression can resume (van Vugt et al., 2005) . However, data from Saccharomyces Cerevisiae and Xenopus have suggested that there may be an alternative route to re-enter cell cycle progression even in the presence of unrepaired DNA damage, namely through a process termed 'checkpoint adaptation' (Figure 1 ). This process was originally defined in S. Cerevisiae as the ability to divide in the presence of irrepairable DNA breaks (Sandell and Zakian, 1993; Toczyski et al., 1997; Yoo et al., 2004) . When exposed to an extra chromosome lacking telomeres, or an irrepairable endonucleolytic DNA double-strand break, S. cerevisiae cells first entered a G2/M arrest. However, this G2/M arrest could not be maintained and cells adaptated and eventually resumed cell cycle progression ( (Sandell and Zakian, 1993; Toczyski et al., 1997) , Figure 1a) . A similar process was described in Xenopus egg extracts containing the replication inhibitor aphidicolin. Following the initial checkpoint arrest in S phase, these extracts adapted and entered mitosis in the presence of incompletely replicated DNA (Yoo et al., 2004; Figure 1b) .
As checkpoint responses are often conserved from yeast, Xenopus to mammals, an important unanswered question has been whether checkpoint adaptation also occurs in human cells (Lupardus and Cimprich, 2004) . To address this issue, we recently studied the termination of the G2 checkpoint in response to lethal doses of IR (Syljua˚sen et al., 2006) . Our findings strongly suggested that checkpoint adaptation occurs also in human cells. This process may potentially promote genomic instability and human carcinogenesis.
Evidence for checkpoint adaptation in human cells
Although checkpoint adaptation has long been considered unlikely in human cells (Lupardus and Cimprich, 2004; Harrison and Haber, 2006) , common knowledge about cellular responses to IR in fact suggests that such a process may occur in IR-treated cells. For example, cancer cells typically undergo one or several rounds of cell division before they die after IR (Hall and Giaccia, 2006) . Such IR-induced cell death has been termed 'mitosis-linked cell death' or 'post-mitotic death', as the cells are passing through mitosis before they die at later stages (Dewey et al., 1995; Jonathan et al., 1999; Hall and Giaccia, 2006) . The notion that cells carrying lethal damage are dividing, and therefore must have terminated the G2 checkpoint to allow mitotic entry of damaged cells, is consistent with checkpoint adaptation.
Another indication that checkpoint adaptation may occur in human cells comes from studies of the IRinduced chromosome aberrations. It has long been known that chromosome aberrations are induced in a radiation dose-dependent manner in human cells, which can be visualized when a preparation is made at the first metaphase after IR (Hall and Giaccia, 2006) . Human cells containing chromosome damage therefore clearly are capable of terminating the G2 checkpoint, even despite presence of aberrations such as gaps, chromatid breaks or acentric fragments. The presence of mitotic IR-treated human cells with such lesions is consistent with a process of adaptation to allow mitotic entry of cells with DNA breaks. Similarly, it was pointed out that IR-treated plant cells must have undergone G2 checkpoint adaptation as they entered mitosis with chromatid breaks (Carballo et al., 2006) .
We therefore recently hypothesized that adaptation to the IR-induced G2 checkpoint likely occurs in human cells (Figure 2 ). To verify this hypothesis, we searched for signs of unrepaired DNA breaks in human cells that had entered mitosis following a sustained IR-induced G2 checkpoint. We found that following a sustained G2 checkpoint, human osteosarcoma cells entered mitosis with g-H2AX foci, a common marker for double-strand breaks ( Figure 3 and Syljua˚sen et al., 2006) . At 30 h after 6 Gy, about 30% of the mitotic cells that appeared following arrest at the G2 checkpoint contained more than 10 g-H2AX foci (Syljua˚sen et al., 2006) . As the number of g-H2AX foci correlates with unrepaired DSBs in IR-treated human cells , each single g-H2AX focus in the mitotic osteosarcoma cells may represent one unrepaired double-strand break. However, g-H2AX may persist on rejoined chromosomes (Forand et al., 2004; Suzuki et al., 2006) and even became duplicated during replication in progenies of IR-treated cells (Klokov et al., 2006) , suggesting that g-H2AX may also represent other lesions related to aberrant chromatin structure or improper repair. Furthermore, g-H2AX staining was increased during apoptosis in a Jun N-terminal kinasedependent fashion (Lu et al., 2006) . Therefore, it is not clear at present what exactly is the DNA lesion behind each g-H2AX focus in the mitotic cells. Anyway, it seems most plausible to assume that at least some of the g-H2AX foci reflect unrepaired strand breaks and checkpoint adaptation therefore occurs in human cells after IR (Figure 2) . Similarly, one report described the presence of g-H2AX foci in mitotic hamster cells after IR . Checkpoint adaptation therefore also likely occurs in cells of hamster origin, although the level of g-H2AX foci in non-irradiated mitotic hamster cells was not shown in that report .
Taken together, our new data in human osteosarcoma cells, combined with previous knowledge about IRinduced responses, strongly support that a process of checkpoint adaptation occurs in human cells.
Molecular mechanisms of checkpoint adaptation in human cells
The molecular mechanisms of checkpoint adaptation in human cells are largely unknown. As checkpoint mechanisms are often conserved, the mechanisms identified in yeast and Xenopus may provide helpful leads. Also, suggestions may come from recent progress that has been made towards understanding mechanisms of 'checkpoint recovery' in human cells, that is, the process allowing termination of the checkpoint after the DNA damage has been repaired. In S. cerevisiae, checkpoint recovery shares some, but not all genetic requirements with checkpoint adaptation (Harrison and Haber, 2006) .
In S. cerevisiae, analysis of strains deleted for single proteins have shown that checkpoint adaptation requires the polo-like kinase (Cdc5p), the casein kinase II subunits (Ckb1 and Ckb2) and the phosphatases Ptc2 and Ptc3 (Toczyski et al., 1997; Leroy et al., 2003) . Inactivation of checkpoint kinase Rad53 is also required Lupardus and Cimprich, 2004) . The function of S. cerevisiae Rad53 most often parallels that of human Chk1, although the structural homolog to S. cerevisiae Rad53 is human Chk2 (Matsuoka et al., 1998) . Cdc5 mutant strains lacked the usual downregulation of Rad53 kinase activity in response to DNA (a) In S. cerevisiae, checkpoint adaptation occurs in G2/M phase in response to irrepairable DNA double-strand breaks (Sandell and Zakian, 1993; Toczyski et al., 1997) . (b) In Xenopus extracts, checkpoint adaptation occurs in S phase in the presence of the replication inhibitor Aphidicholin (Yoo et al., 2004) .
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Mitotic entry Mitotic entry Figure 2 Two alternative routes for mitotic entry following induction of the IR-induced G2 checkpoint. The G2 checkpoint is induced by DNA damage caused by IR. Mitotic entry occurs after the DNA breaks have been fully repaired, or after a process of adaptation that allows cell division with unrepaired DNA lesions.
Checkpoint adaptation RG Syljuåsen breaks, suggesting a link between the yeast polo-like kinase and Rad53 . Furthermore, Rad53 is a common target of the Ptc2 and Ptc3 phosphatases, and Ptc2 is in turn a phosphorylation substrate of Ckb1 and Ckb2 (Leroy et al., 2003; Harrison and Haber, 2006) . Thus, in yeast, both Cdc5, Ptc2, Ptc3, Ckb1 and Ckb2 seem to merge on a common pathway involving inactivation of Rad53 as the key event triggering checkpoint adaptation (Harrison and Haber, 2006) . In addition, several proteins that function in recombination and repair are required for checkpoint adaptation in S. cerevisiae, such as Ku70, the Rad54 homolog Tid1 and Rad51 (Lee et al., 1998 Harrison and Haber, 2006) . These proteins may control adaptation because they affect the extent of single-stranded DNA at broken chromosomes (Lee et al., 1998) , and in their absence the damage signals are increased resulting in a stronger checkpoint that may be harder to overcome.
A link between the polo-like kinase and Chk1 was also shown in adaptation to the aphidicolin-induced replication checkpoint in Xenopus (Yoo et al., 2004) . This mechanism involved Plk1-mediated direct phosphorylation of Claspin, which caused release of Claspin from the chromatin and thereby inactivation of Chk1 owing to lack of Claspin-mediated Chk1 phosphorylation (Yoo et al., 2004) . Furthermore, a similar link between Plk1 and Chk1 was recently demonstrated in response to DNA damage induced by HU or adriamycin during checkpoint recovery in human cells, although in human cells Claspin is degraded in contrast to being released from the chromatin (Mailand et al., 2006; Peschiaroli et al., 2006) . Plk1-mediated phosphorylation triggers recognition of Claspin by the b-TrCP-SCF ubiquitin ligase and ubiquitin-dependent degradation, and thereby promotes inactivation of Chk1 owing to reduced Chk1 phosphorylation (Mailand et al., 2006; Mamely et al., 2006; Peschiaroli et al., 2006) . In another report, Plk1 was shown to control checkpoint recovery in human cells by phosphorylating Wee1 (van Vugt et al., 2004) . Plk1 directly phosphorylates Wee1, leading to degradation of Wee1 and less inhibitory phosphorylations on the mitosis-promoting complex Cdk1/ cyclin B (van Vugt et al., 2004) . In addition, the human phosphatase Cdc25B, but not Cdc25A or Cdc25C, was required for checkpoint recovery (van Vugt et al., 2004) .
We showed that adaptation to the IR-induced G2 checkpoint in human cells requires Plk1 kinase, as depletion of Plk1 by small interfering RNA (siRNA) prevented mitotic entry in later stages after DNA damage (Syljua˚sen et al., 2006) . Furthermore, the sustained IR-induced G2 checkpoint was Chk1-dependent (Syljua˚sen et al., 2006) . We also showed that Chk1 is dephosphorylated as cells entered mitosis. However, in our assays we could not distinguish between whether dephosphorylation of Chk1 occurred as the priming event in G2 phase to drive mitotic entry during the adaptation process, or alternatively, as a consequence of checkpoint adaptation in early M phase.
Similar to adaptation in yeast and Xenopus and checkpoint recovery in human cells, human Plk1 may also cause Chk1 inactivation during adaptation to the IR-induced G2 checkpoint, although this link remains to be proven. Plk1 does not seem to directly phosphorylate Chk1 (Syljua˚sen et al., 2006) . Furthermore, shRNA-mediated depletion of Claspin did not accelerate mitotic entry following the IR-induced G2 checkpoint (RG Syljua˚sen, unpublished results), and transfection with Claspin siRNA rather seemed to prolong the G2-phase accumulation (Lin et al., 2004) . Thus, Plk1-mediated degradation of Claspin is not likely sufficient to trigger adaptation to the IR-induced G2 checkpoint, in contrast to the proposed role of Claspin degradation in checkpoint recovery following the replication checkpoint induced by HU (Mailand et al., 2006; Peschiaroli et al., 2006) . However, our data do not exclude that Claspin degradation may contribute to the adaptation process. In theory, many other possibilities exist for a link between Plk1 and Chk1, such as Plk1-mediated control of phosphatases that dephosphorylate Chk1 (den Elzen et al., 2004; Lu et al., 2005) , or of the checkpoint mediators Brca1, Rpa or Atrip (Kim et al., 2005; Yoo et al., 2006) . Recently, it was shown in Xenopus extracts that co-depletion of Claspin and Brca1 was necessary to achieve complete inhibition of Chk1 phosphorylation (Yoo et al., 2006) . However, in human cells co-depletion of Brca1 and Claspin did not further reduce Chk1 phosphorylation compared to depletion of Claspin or Brca1 alone (Lin et al., 2004) .
Plk1 and Chk1 may also act on parallel pathways during adaptation to the IR-induced G2 checkpoint, converging on a common target that controls mitotic entry, such as Cyclin B/Cdk1. The level of inhibitory phosphorylations on Cyclin B/Cdk1 is decreased by Plk1-mediated degradation of the kinase Wee1 (van Vugt et al., 2004) , and increased by Chk1-mediated inhibition of the Cdc25 phosphatases (Chen and Sanchez, 2004) . Both Plk1 and Chk1 could therefore regulate Cyclin B/Cdk1 activity and mitotic entry after IR in parallel pathways, without necessarily Plk1 being required for Chk1 inactivation.
Recent evidence suggests that proper timing of mitotic entry is controlled by activation of centrosomal cyclin B/Cdk 1 (De Souza et al., 2000; Kramer et al., 2004) . A role of centrosomal signaling in checkpoint responses to DNA damage was also proposed, although the present evidence is scarce (Loffler et al., 2006) . As both Plk1 and Chk1 localize to the centrosomes (Arnaud et al., 1998; Kramer et al., 2004) , centrosomal signaling could potentially play a role in checkpoint adaptation, albeit this connection is entirely speculative at present.
A key issue is to identify the upstream signal that triggers checkpoint adaptation. In Xenopus extracts, adaptation to aphidicolin-induced replication damage was triggered by gradual accumulation of Plk1 activity (Yoo et al., 2004) . Accumulation of Plk1 activity was dependent on ATR-mediated phosphorylation, and adaptation occurred when Plk1 activity accumulated to a sufficient level to phosphorylate Claspin (Yoo et al., 2004) . Therefore, adaptation in Xenopus is not the result of an active decision-making process, but rather seemed a result of prolonged time at the ATR-dependent checkpoint (Lupardus and Cimprich, 2004) . In preliminary experiments, we were unable to detect an increase in Plk1 kinase activity during the IR-induced G2-arrest in our human osteosarcoma cells, although Plk1 kinase activity was clearly elevated in mitotic extracts (RG Syljua˚sen, unpublished data). The signal triggering adaptation to the IR-induced G2 checkpoint in human cells may therefore differ from aphidicolintreated Xenopus extracts, or the increases in Plk1 activity may be transient or local and therefore not detected in our assays.
In addition to Plk1, there are several other mitosis promoting factors that potentially could accumulate with prolonged time in G2 phase and thereby trigger checkpoint adaptation. One example is cyclin B. Transcription of cyclin B is transiently reduced after IR (Muschel et al., 1992) , however, cyclin B levels increase during prolonged G2 arrest (Maity et al., 1996) , and overexpression of cyclin B after IR shortened the G2 checkpoint in HeLa cells (Kao et al., 1997) . In fact, gradual accumulation of cyclin B during prolonged time in G2 phase was proposed as the key event triggering termination of the IR-induced G2 checkpoint in HeLa cells (Ianzini and Mackey, 1997) .
Based on previous reports that tumor suppressor p53 is required to maintain the IR-induced G2 checkpoint in human cells (Bunz et al., 1998) , lack of functional p53 may also contribute to enhance the adaptation process, although others found p53 dispensible for the G2 checkpoint (Koniaras et al., 2001) . Our experimental evidence of checkpoint adaptation was in human cells that contained wild-type p53 (Syljua˚sen et al., 2006) . Thus, adaptation in human cells does not require p53 deficiency.
Altogether, the mechanisms of checkpoint adaptation in human cells are only beginning to be understood. Although data are sparse and current models therefore are highly hypothetical, the data point towards cyclin B/ Cdk1 as having a central role in this process. Cyclin B/ Cdk1 activity is regulated by multiple factors including cyclin B transcription, nuclear exclusion signals and inhibitory phosphorylations (Takizawa and Morgan, 2000) , the latter being controlled by Chk1 and Plk1 (Chen and Sanchez, 2004; van Vugt et al., 2004) . Making the assumption that cyclin B/Cdk1 is a key regulator of mitotic entry following arrest at the IRinduced G2 checkpoint, every signaling pathways that influence on Cyclin B/Cdk1 activity potentially might regulate adaptation (Figure 4) . Finally, as mitotic entry is a tightly controlled process involving signaling pathways and kinases in addition to cyclin B/Cdk1 (Furuno et al., 1999) , other factors may also likely be involved.
Consequences of checkpoint adaptation
Division of cells with damaged DNA clearly increases the risk of genomic instability and cancer development. Although most of the cells will die following adaptation, some cells containing damaged DNA might survive and propagate with unstable genomes (Figure 5) . Therefore, checkpoint adaptation in human cells may contribute to carcinogenesis. Indeed, studies in S. cerevisiae suggest that checkpoint adaptation causes genomic instability, as adaptation defective mutants showed decreased X-ray-induced chromosome loss and translocations (Galgoczy and Toczyski, 2001 ).
On the other hand, adaptation has been proposed to be the first step in a death pathway, by moving cells into a phase where they can die (Lupardus and Cimprich, 2004) . With regard to IR-induced post-mitotic cell death, human cells cultured in vitro typically die in an asynchronous manner over several post-irradiation generations by various death pathways such as necrosis and apoptosis, and by permanent cell-cycle arrest (Linke et al., 1997; Chu et al., 2002; Hall and Giaccia, 2006) . Such cells probably die owing to the lack of transcription of essential genes, which is caused by the chromosome damage (Forrester et al., 2000) . In fact, examples have been shown where progenies from the two daughters of a single IR-treated cell behave differently in terms of survival/death; some of the progenies died, whereas others survived (Thompson and Suit, 1969; Chu et al., 2002) . Therefore, IR-induced post-mitotic death appears to occur in a stochastic manner, rather than through a decision-making programmed process (Brown and Attardi, 2005) . Adaptation to the IR-induced G2 checkpoint is thus not likely the first step of a programmed death pathway. However, adaptation is clearly an event that precedes IR-induced cell death. If adaptation was inhibited, would IR-treated cells then eventually die by alternative mechanisms in G2 phase? Perhaps IR-treated cells are unable to die in G2 phase, and therefore adaptation is needed to allow death to occur at later stages, though in a slow, stochastic fashion. In S. cerevisiae, studies of adaptation defective mutants showed that adaptation is required for maximal survival following DNA damage (Galgoczy and Toczyski, 2001) . Furthermore, such mutants showed reduced repair of DNA breaks by the repair process 'break-induced replication', suggesting that adaptation may occur to allow proper repair of the damage in other cell cycle phases (Galgoczy and Toczyski, 2001) . One may speculate that adaptation in human cells similarly could facilitate repair of difficult DNA lesions by allowing progression into other phases (Lupardus and Cimprich, 2004) .
Taken together, checkpoint adaptation followed by a stochastic death process does not seem an optimal way to eliminate potentially genomic unstable cells in response to IR. However, such post-mitotic death may be the most effective death pathway available for many cell types that are not prone to apoptosis (and therefore cannot be eliminated by a rapid induction of apoptosis after IR). In addition to in vitro cell culture studies, it will be important to determine the extent of checkpoint adaptation in vivo, as checkpoint adaptation might be influenced by the in vitro growth conditions. We propose that adaptation to the G2 checkpoint may contribute to IR-induced genomic instability in human cells ( Figure 5 ). Another reasoning may be that checkpoint adaptation exists to allow natural evolution, perhaps at the cost of danger for genomic instability. In this context it will be important to address whether adaptation occurs in an environment at 'physiological' levels of stress, as the present experimental evidence of adaptation in human cells (Syljua˚sen et al., 2006) was obtained at damage levels much higher than in an unperturbed, physiological environment. An analogous process to checkpoint adaptation in human cells may be translesion synthesis during DNA replication (Friedberg et al., 2002) , which also allows cell cycle progression in the presence of DNA lesions.
Conclusion
Recent evidence suggests that checkpoint adaptation is not a process limited to S. cerevisiae and Xenopus extracts. Most notably, adaptation also occurs in IRtreated human cells. Future studies will reveal the extent of checkpoint adaptation in a broader range of normal 
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Mitotic entry of cells with damaged DNA Figure 4 Hypothetical model for control of adaptation to the IRinduced G2 checkpoint in human cells. Unrepairable DNA breaks lead to a sustained G2 checkpoint, which is likely enforced by suppression of cyclin B/Cdk1 activity. Cyclin B/Cdk1 activity is regulated by multiple factors including transcription of cyclin B and the extent of inhibitory phosphorylations on Cdk1, the latter being controlled by Plk1 and Chk1. Similar to adaptation in aphidicolin-treated Xenopus extracts, Plk1 may also control Chk1-inactivation during checkpoint adaptation in human cells. 
